/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

A

Adrian Tase

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

17

Papers

3.5K

Citations

3

h-index

3

i10-index

Adrian Tase is an academic researcher. The author has contributed to research in topics: Chemotherapy-induced cardiotoxicity and mitigation & Cancer Treatment and Pharmacology & Blood Pressure and Hypertension Studies. The author has an h-index of 3, co-authored 15 publications.

Research Topics

Chemotherapy-induced cardiotoxicity and mitigation Cancer Treatment and Pharmacology Blood Pressure and Hypertension Studies Heart Failure Treatment and Management Healthcare Policy and Management

Papers by this author

works

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

2019 · The Lancet · 2,820 citations

https://doi.org/10.1016/s0140-6736(19)31149-3

Hertzel C. Gerstein Helen M. Colhoun Gilles R. Dagenais Rafael Díaz

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

2019 · The Lancet · 600 citations

https://doi.org/10.1016/s0140-6736(19)31150-x

Hertzel C. Gerstein Helen M. Colhoun Gilles R. Dagenais Rafael Díaz

Research topics

topics

Chemotherapy-induced cardiotoxicity and mitigation

Cancer Treatment and Pharmacology

Blood Pressure and Hypertension Studies

Heart Failure Treatment and Management

Healthcare Policy and Management

Chat about Author

Papers

Chat

Click to start Chat